Clinical Trials
-
Principal Investigator:
Nobuko Hijiya, MDThe purpose of this study is to determine if a study drug called pembrolizumab is safe and effective in the treatment of children and adolescents who have advanced melanoma, or advanced, relapsed, or refractory PD-L1 positive malignant solid tumor or other lymphoma, relapsed or refractory classical Hodgkin lymphoma (rrcHL), advanced, relapsed or refractory microsatellite-instability-high (MSI-H) solid tumor. Participants might be at least 6 months ( 3 years rrcHL) to less than 18 years old and able to provide the sample for testing the PD-L1 (programmed cell death ligand 1) purpose from an... -
Principal Investigator:
Mercedes Martinez, MDThe purpose of this study is to better understand how common and how severe pruritis (itching) is in children and adults under 21 years of age with Primary Sclerosing Cholangitis (PSC). The study involves the completion of two short online surveys. If you have any questions regarding this study, please contact the Transplant Clinical Research Center ( TCRC). -
Principal Investigator:
Mercedes Martinez, MDThe purpose of this study is to better understand how common and how severe pruritis (itching) is in children and adults under 21 years of age with Primary Sclerosing Cholangitis (PSC). The study involves the completion of two short online surveys. If you have any questions regarding this study, please contact the Transplant Clinical Research Center ( TCRC). -
Principal Investigator:
Meyer Kattan, MDWe are interested in learning more about these diseases and how to treat them. Our research program is conducting several studies including: a study to learn if treatment with a drug named dupilumab can help reduce asthma attacks in children, a study to observe a specific type of irritation in the lungs and how it relates to asthma symptoms, and more! If you live in the city or surrounding counties and have an interest in participating in research studies, you may be eligible to join a registry of participants. Our research focuses on children, but all ages are eligible to join. Contribute to... -
Principal Investigator:
Meyer Kattan, MDWe are interested in learning more about these diseases and how to treat them. Our research program is conducting several studies including: a study to learn if treatment with a drug named dupilumab can help reduce asthma attacks in children, a study to observe a specific type of irritation in the lungs and how it relates to asthma symptoms, and more! If you live in the city or surrounding counties and have an interest in participating in research studies, you may be eligible to join a registry of participants. Our research focuses on children, but all ages are eligible to join. Contribute to... -
Principal Investigator:
Ilene Fennoy, MDWe know that puberty is a major time of change! Adolescents develop new decision-making skills and independence. It is possible that some of these changes are due to the hormonal changes during puberty. One of the ways we treat transgender and gender non-conforming teens is to suppress or "block" puberty. We know that this is a safe thing to do for teens because we use it in people who start puberty too early (precocious puberty) and in people who are born very small in order to prolong their growth potential. We are doing this study to continue to understand the impact of this therapy on... -
Principal Investigator:
Dani Dumitriu, MD, PhDThis study aims to understand the impact of the COVID-19 pandemic on mother and infant health outcomes in pregnant women delivering at NewYork-Presbyterian Morgan Stanley Children's Hospital or Allen Pavilion Hospital. Data will be collected through online surveys, video visits, and electronic health records. Additionally, surveys will be distributed to physicians and other healthcare workers involved in newborn care to ask them about their clinical practices during the pandemic. -
Principal Investigator:
Dani Dumitriu, MD, PhDThis study aims to understand the impact of the COVID-19 pandemic on mother and infant health outcomes in pregnant women delivering at NewYork-Presbyterian Morgan Stanley Children's Hospital or Allen Pavilion Hospital. Data will be collected through online surveys, video visits, and electronic health records. Additionally, surveys will be distributed to physicians and other healthcare workers involved in newborn care to ask them about their clinical practices during the pandemic. -
Principal Investigator:
Vidhu Thaker, MDWe will enroll children with severe early-onset obesity (BMI - 99th percentile) diagnosed prior to 6 years of age. We will ask questions about their health, eating behavior and perform a brief physical examination. We will collect saliva or blood to perform genetic testing. We will also invite family members to participate in the genetic study. -
Principal Investigator:
Michael Philip DiLorenzo, MDDown syndrome (DS) occurs in roughly 1 out of 700 births in the U.S. Half of all children with Down syndrome have congenital heart disease (CHD), often requiring corrective heart surgery. Even though CHD in children without DS is known to be associated with developmental problems, few studies have explored how CHD can affect the development and behavior of children with DS. In this research study, we want to learn whether having CHD and infant heart surgery affects the way children with DS develop and learn. We would like to compare children with DS who have had CHD and infant heart surgery...